{
    "info": {
        "nct_id": "NCT03275285",
        "official_title": "Randomized, Open Label, Multicenter Study Assessing The Clinical Benefit Of Isatuximab Combined With Carfilzomib (KyprolisÂ®) And Dexamethasone Versus Carfilzomib With Dexamethasone In Patients With Relapse And/Or Refractory Multiple Myeloma Previously Treated With 1 to 3 Prior Lines",
        "inclusion_criteria": "Inclusion criteria:\n\n* Participants with MM previously treated with prior 1 to 3 lines and with measurable serum M-protein (>= 0.5 gram/deciliter) and/or urine M-protein (>= 200 milligram/24 hours).\n\nExclusion criteria:\n\n* Participants previously pretreated with carfilzomib, who never achieved at least one minor response during previous therapies and/or last previous therapy completed within 14 last days.\n* Participants with serum free light chain (FLC) measurable disease only.\n* Participants less than 18 years old, participants with Eastern Cooperative Oncology Group performance status more than 2.\n* Participants with inadequate biological tests.\n* Participants with myocardial infarction, severe/unstable angina pectoris, coronary/peripheral artery bypass graft, New York Heart Association class III or IV congestive heart failure, superior or equal to grade 3 arrhythmias, stroke or transient ischemic attack within last 6 months, and/or left ventricular ejection fraction lower than 40%.\n* Participants with previous cancer unless disease free for more than 5 years or in situ cancer curatively treated.\n* Participants with known acquired immunodeficiency syndrome related illness or human immunodeficiency virus requiring antiretroviral treatment, or hepatitis A, B, or C active infection.\n* Women of childbearing potential or male participant with women of childbearing potential who do not agree to use highly effective method of birth control.\n\nThe above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Participants with known acquired immunodeficiency syndrome related illness or human immunodeficiency virus requiring antiretroviral treatment, or hepatitis A, B, or C active infection.",
            "criterions": [
                {
                    "exact_snippets": "known acquired immunodeficiency syndrome related illness",
                    "criterion": "acquired immunodeficiency syndrome (AIDS) related illness",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "human immunodeficiency virus requiring antiretroviral treatment",
                    "criterion": "human immunodeficiency virus (HIV) infection",
                    "requirements": [
                        {
                            "requirement_type": "treatment requirement",
                            "expected_value": "requiring antiretroviral treatment"
                        }
                    ]
                },
                {
                    "exact_snippets": "hepatitis A, B, or C active infection",
                    "criterion": "hepatitis A infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        }
                    ]
                },
                {
                    "exact_snippets": "hepatitis A, B, or C active infection",
                    "criterion": "hepatitis B infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        }
                    ]
                },
                {
                    "exact_snippets": "hepatitis A, B, or C active infection",
                    "criterion": "hepatitis C infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with serum free light chain (FLC) measurable disease only.",
            "criterions": [
                {
                    "exact_snippets": "serum free light chain (FLC) measurable disease only",
                    "criterion": "serum free light chain (FLC) measurable disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "measurability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "exclusivity",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants less than 18 years old, participants with Eastern Cooperative Oncology Group performance status more than 2.",
            "criterions": [
                {
                    "exact_snippets": "Participants less than 18 years old",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": "<",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "participants with Eastern Cooperative Oncology Group performance status more than 2",
                    "criterion": "Eastern Cooperative Oncology Group performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Women of childbearing potential or male participant with women of childbearing potential who do not agree to use highly effective method of birth control.",
            "criterions": [
                {
                    "exact_snippets": "Women of childbearing potential ... do not agree to use highly effective method of birth control",
                    "criterion": "women of childbearing potential",
                    "requirements": [
                        {
                            "requirement_type": "contraception agreement",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "contraception method effectiveness",
                            "expected_value": "highly effective"
                        }
                    ]
                },
                {
                    "exact_snippets": "male participant with women of childbearing potential ... do not agree to use highly effective method of birth control",
                    "criterion": "male participant with partner of childbearing potential",
                    "requirements": [
                        {
                            "requirement_type": "contraception agreement",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "contraception method effectiveness",
                            "expected_value": "highly effective"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with MM previously treated with prior 1 to 3 lines and with measurable serum M-protein (>= 0.5 gram/deciliter) and/or urine M-protein (>= 200 milligram/24 hours).",
            "criterions": [
                {
                    "exact_snippets": "MM previously treated with prior 1 to 3 lines",
                    "criterion": "number of prior lines of therapy for multiple myeloma",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 1,
                                        "unit": "lines"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "lines"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "measurable serum M-protein (>= 0.5 gram/deciliter)",
                    "criterion": "serum M-protein",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 0.5,
                                "unit": "gram/deciliter"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "urine M-protein (>= 200 milligram/24 hours)",
                    "criterion": "urine M-protein",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 200,
                                "unit": "milligram/24 hours"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with previous cancer unless disease free for more than 5 years or in situ cancer curatively treated.",
            "criterions": [
                {
                    "exact_snippets": "Participants with previous cancer unless disease free for more than 5 years",
                    "criterion": "previous cancer",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "disease free duration",
                            "expected_value": {
                                "operator": ">",
                                "value": 5,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "in situ cancer curatively treated",
                    "criterion": "in situ cancer",
                    "requirements": [
                        {
                            "requirement_type": "curative treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with inadequate biological tests.",
            "criterions": [
                {
                    "exact_snippets": "inadequate biological tests",
                    "criterion": "biological tests",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants previously pretreated with carfilzomib, who never achieved at least one minor response during previous therapies and/or last previous therapy completed within 14 last days.",
            "criterions": [
                {
                    "exact_snippets": "Participants previously pretreated with carfilzomib",
                    "criterion": "prior carfilzomib treatment",
                    "requirements": [
                        {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "never achieved at least one minor response during previous therapies",
                    "criterion": "response to previous therapies",
                    "requirements": [
                        {
                            "requirement_type": "minor response achieved",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "last previous therapy completed within 14 last days",
                    "criterion": "time since last previous therapy",
                    "requirements": [
                        {
                            "requirement_type": "time since completion",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with myocardial infarction, severe/unstable angina pectoris, coronary/peripheral artery bypass graft, New York Heart Association class III or IV congestive heart failure, superior or equal to grade 3 arrhythmias, stroke or transient ischemic attack within last 6 months, and/or left ventricular ejection fraction lower than 40%.",
            "criterions": [
                {
                    "exact_snippets": "myocardial infarction ... within last 6 months",
                    "criterion": "myocardial infarction",
                    "requirements": [
                        {
                            "requirement_type": "history within last 6 months",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "severe/unstable angina pectoris ... within last 6 months",
                    "criterion": "severe/unstable angina pectoris",
                    "requirements": [
                        {
                            "requirement_type": "history within last 6 months",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "coronary/peripheral artery bypass graft ... within last 6 months",
                    "criterion": "coronary artery bypass graft",
                    "requirements": [
                        {
                            "requirement_type": "history within last 6 months",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "coronary/peripheral artery bypass graft ... within last 6 months",
                    "criterion": "peripheral artery bypass graft",
                    "requirements": [
                        {
                            "requirement_type": "history within last 6 months",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "New York Heart Association class III or IV congestive heart failure",
                    "criterion": "congestive heart failure",
                    "requirements": [
                        {
                            "requirement_type": "NYHA class",
                            "expected_value": [
                                "III",
                                "IV"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "superior or equal to grade 3 arrhythmias",
                    "criterion": "arrhythmias",
                    "requirements": [
                        {
                            "requirement_type": "severity grade",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "grade"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "stroke or transient ischemic attack within last 6 months",
                    "criterion": "stroke",
                    "requirements": [
                        {
                            "requirement_type": "history within last 6 months",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "stroke or transient ischemic attack within last 6 months",
                    "criterion": "transient ischemic attack",
                    "requirements": [
                        {
                            "requirement_type": "history within last 6 months",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "left ventricular ejection fraction lower than 40%",
                    "criterion": "left ventricular ejection fraction",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": "<",
                                "value": 40,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "Exclusion criteria:",
            "criterions": []
        },
        {
            "line": "Inclusion criteria:",
            "criterions": []
        },
        {
            "line": "The above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.",
            "criterions": []
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}